3 ms·
> If we end up with a treatment that swings infection fatality rate from 0.6% to 0.55% and reduces hospital stay time by 15% Unsure about fatality (the data is
by lbeltrame 6y ago
> If we end up with a treatment that swings infection fatality rate from 0.6% to 0.55% and reduces hospital stay time by 15%
Unsure about fatality (the data is a statistically insignificant trend), but the NIAID trial preliminary data points that remedesivir does cut recovery time by 30% (11 days vs 14 days) according to their interim report. I have to dig up the exact definition.
Yes, not HCQ, but data on drugs exist. Too bad it's probably one of the hardest to manufacture.
- mlyle 6y agoOK, but this has nothing to do with what I said. Even cutting recovery time by 22% doesn't lower peak ICU usage very much-- less than 22% because there's still the effect of the exponential peak. The point is it doesn't affect policy / the fundamentals of the situation in any way. It's something that individual patients are happy and thankful for, but the overall societal situation is the same. A treatment that reduced the chance of ending up in ICU by 50% would, but this isn't enough to move the needle.